Picard C, Bobby Gaspar H, Al-Herz W, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol. 2018;38(1):96–128. https://doi.org/10.1007/s10875-017-0464-9.

Article  PubMed  Google Scholar 

Bousfiha A, Jeddane L, Picard C, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40(1):66–81. https://doi.org/10.1007/s10875-020-00758-x.

Article  PubMed  PubMed Central  Google Scholar 

Bonilla FA, Geha RS. Primary immunodeficiency diseases. J Allergy Clin Immunol. 2003;111(2 SUPPL. 2):571–81. https://doi.org/10.1067/mai.2003.86.

Article  CAS  Google Scholar 

Tangye SG, Al-Herz W, Bousfiha A, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–1507. https://doi.org/10.1007/s10875-022-01289-3

Castagnoli R, Notarangelo LD. Updates on new monogenic inborn errors of immunity. Pediatr Allergy Immunol. 2020;31(S26):57–9. https://doi.org/10.1111/pai.13365.

Article  PubMed  PubMed Central  Google Scholar 

Slatter MA, Gennery AR. Hematopoietic cell transplantation in primary immunodeficiency–conventional and emerging indications. Expert Rev Clin Immunol. 2018;14(2):103–14. https://doi.org/10.1080/1744666X.2018.1424627.

Article  CAS  PubMed  Google Scholar 

Nishimura A, Miyamoto S, Imai K, Morio T. Conditioning regimens for inborn errors of immunity: current perspectives and future strategies. Int J Hematol. 2022;116(1):7–15. https://doi.org/10.1007/s12185-022-03389-7.

Article  PubMed  Google Scholar 

Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives. Front Pediatr. 2019;7(August):1–25. https://doi.org/10.3389/fped.2019.00295.

Article  Google Scholar 

Bertaina A, Zecca M, Buldini B, et al. Unrelated donor vs HLA-haploidentical a/b T-cell– and B-cell–depleted HSCT in children with acute leukemia. Blood. 2018;132(24):2594–607. https://doi.org/10.1182/blood-2018-07-861575.

Article  CAS  PubMed  Google Scholar 

Passweg JR, Baldomero H, Basak GW, et al. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant. 2019;54(10):1575–85. https://doi.org/10.1038/s41409-019-0465-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lankester AC, Albert MH, Booth C, et al. EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transplant. 2021;56(9):2052–62. https://doi.org/10.1038/s41409-021-01378-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laberko A, Mukhina A, Machneva E, et al. Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation. J Clin Immunol. 2023;43(6):1241–9. https://doi.org/10.1007/s10875-023-01476-w.

Article  CAS  PubMed  Google Scholar 

Klein OR, Bonfim C, Abraham A, et al. Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering. Cytotherapy. 2023;25(5):463–71. https://doi.org/10.1016/j.jcyt.2022.12.005.

Article  CAS  PubMed  Google Scholar 

Umeda K. Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases. Int J Hematol. 2022;116(1):41–7. https://doi.org/10.1007/s12185-022-03361-5.

Article  PubMed  Google Scholar 

Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97(4):855–64. https://doi.org/10.1046/j.1365-2141.1997.1112925.x.

Article  CAS  PubMed  Google Scholar 

Lee SJ. Classification systems for chronic graft-versus-host disease. Blood. 2017;129(1):30–7. https://doi.org/10.1182/blood-2016-07-686642.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15(12):1628–33. https://doi.org/10.1016/j.bbmt.2009.07.004.

Article  PubMed  PubMed Central  Google Scholar 

Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: One size does not fit all. Blood. 2014;124(3):344–53. https://doi.org/10.1182/blood-2014-02-514778.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miyamoto S. Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other Than Severe Combined Immunode ciency in Japan : Retrospective Analysis for 1985 – 2016. 2016. J Clin Immunol. 2022;42(3):529–545. https://doi.org/10.1007/s10875-021-01199-w

Raj R, Aboobacker FN, Yadav SP, et al. Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India. Front Immunol. 2021;11(January):1–7. https://doi.org/10.3389/fimmu.2020.606930.

Article  CAS  Google Scholar 

Fernandes JF, Nichele S, Daudt LE, et al. Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries. J Clin Immunol. 2018;38(8):917–26. https://doi.org/10.1007/s10875-018-0564-1.

Article  PubMed  Google Scholar 

Rousso SZ, Shamriz O, Zilkha A, et al. Hematopoietic Stem Cell Transplantations for Primary Immune Deficiencies: 3 Decades of Experience from a Tertiary Medical Center. J Pediatr Hematol Oncol. 2015;37(5):e295–300. https://doi.org/10.1097/MPH.0000000000000352.

Article  CAS  PubMed  Google Scholar 

Dell’Orso G, Bagnasco F, Giardino S, et al. Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience. Front Immunol. 2023;14(February):1–10. https://doi.org/10.3389/fimmu.2023.1103080.

Article  CAS  Google Scholar 

Anasetti C, Logan BR, Lee SJ, et al. Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors. N Engl J Med. 2012;367(16):1487–96. https://doi.org/10.1056/nejmoa1203517.

Article  CAS  PubMed  Google Scholar 

Meisel R, Klingebiel T, Dilloo D. Peripheral blood stem cells versus bone marrow in pediatric unrelated donor stem cell transplantation. Blood. 2013;121(5):863–5. https://doi.org/10.1182/blood-2012-12-469668.

Article  CAS  PubMed  Google Scholar 

Kim BK, Hong KT, Choi JY, Kim H, Park HJ, Kang HJ. Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients. Ann Hematol. 2024;103(6):2051–8. https://doi.org/10.1007/s00277-024-05737-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaucha-Prażmo A, Sadurska E, Pieczonka A, et al. Risk factors for transplant outcomes in children and adolescents with non-malignant diseases following allogeneic hematopoietic stem cell transplantation. Ann Transplant. 2019;24:374–82. https://doi.org/10.12659/AOT.915330.

Article  PubMed  PubMed Central  Google Scholar 

Hashem H, Najjar R, Abu-Shanap M, et al. Haploidentical Hematopoietic Cell Transplantation Using Post-transplant Cyclophosphamide for Children with Non-malignant Diseases. J Clin Immunol. 2021;41(8):1754–61. https://doi.org/10.1007/s10875-021-01113-4.

Article  CAS  PubMed  Google Scholar